Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Clinical trial NCT03636906 · COMPLETED

Trial details

NCT number: NCT03636906
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2019-04-08
Primary completion: 2020-01-16
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.